The story on Johnson & Johnson's schizophrenia drug at 9:13 a.m. ET misstated the news. The U.S. Food and Drug Administration approved the drug for sale; the earlier story incorrectly said the drug was approved for priority review.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Johnson and Johnson Charts.